T. van Staa

First name
T.
Middle name
P.
Last name
van Staa
Jones, M. E., Campbell, G., Patel, D., Brunner, E., Shatapathy, C. C., Murray-Thomas, T., et al. (2013). Risk of Mortality (including Sudden Cardiac Death) and Major Cardiovascular Events in Users of Olanzapine and Other Antipsychotics: A Study with the General Practice Research Database. Cardiovasc Psychiatry Neurol. http://doi.org/10.1155/2013/647476
Boggon, R., Hubbard, R., Smeeth, L., Gulliford, M., Cassell, J., Eaton, S., et al. (2013). Variability of antibiotic prescribing in patients with chronic obstructive pulmonary disease exacerbations: a cohort study. BMC Pulm Med. http://doi.org/10.1186/1471-2466-13-32
van Staa, T. P., Smeeth, L., Ng, E. S., Goldacre, B., & Gulliford, M. (2013). The efficiency of cardiovascular risk assessment: do the right patients get statin treatment?. Heart. http://doi.org/10.1136/heartjnl-2013-303698
Atkinson, R. W., Carey, I. M., Kent, A. J., van Staa, T. P., Anderson, H. R., & Cook, D. G. (2013). Long-term exposure to outdoor air pollution and incidence of cardiovascular diseases. Epidemiology. http://doi.org/10.1097/EDE.0b013e318276ccb8
Boggon, R., van Staa, T. P., Chapman, M., Gallagher, A. M., Hammad, T. A., & Richards, M. A. (2013). Cancer recording and mortality in the General Practice Research Database and linked cancer registries. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.3374
van Staa, T. P., Dyson, L., McCann, G., Padmanabhan, S., Belatri, R., Goldacre, B., et al. (2014). The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials. Health Technol Assess. http://doi.org/10.3310/hta18430
Dregan, A., van Staa, T. P., McDermott, L., McCann, G., Ashworth, M., Charlton, J., et al. (2014). Point-of-care cluster randomized trial in stroke secondary prevention using electronic health records. Stroke. http://doi.org/10.1161/strokeaha.114.005713
Gallagher, A. M., van Staa, T. P., Murray-Thomas, T., Schoof, N., Clemens, A., Ackermann, D., & Bartels, D. B. (2014). Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes. BMJ Open. http://doi.org/10.1136/bmjopen-2013-003839
van Staa, T. P., Gulliford, M., Ng, E. S., Goldacre, B., & Smeeth, L. (2014). Prediction of cardiovascular risk using Framingham, ASSIGN and QRISK2: how well do they predict individual rather than population risk?. PLoS One. http://doi.org/10.1371/journal.pone.0106455
van Staa, T. P., Carr, D. F., O\textquoterightMeara, H., McCann, G., & Pirmohamed, M. (2014). Predictors and outcomes of increases in creatine phosphokinase concentrations or rhabdomyolysis risk during statin treatment. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.12367